Načítá se...
Ovarian suppression for adjuvant treatment of hormone receptor‐positive early breast cancer
BACKGROUND: Approximately 80% of breast cancers amongst premenopausal women are hormone receptor‐positive. Adjuvant endocrine therapy is an integral component of care for hormone receptor‐positive breast cancer and in premenopausal women includes oestrogen receptor blockade with tamoxifen, temporary...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2020
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7059882/ https://ncbi.nlm.nih.gov/pubmed/32141074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013538 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|